Summary & Overview
HCPCS J3315: Injection, triptorelin pamoate, 3.75 mg
HCPCS Level II code J3315 denotes the injection formulation of triptorelin pamoate, 3.75 mg, a GnRH agonist used for hormonal suppression in various clinical indications. Nationally, this code is important for accurate medication billing, outpatient infusion administration, and tracking utilization of specialty injectable therapies. Proper coding ensures alignment between clinical services and payer reimbursement policies for physician-administered drugs.
Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of service context, typical sites of care, and payer coverage considerations. The publication covers billing benchmarks and utilization patterns where available, relevant policy updates affecting injectable GnRH agents, and clinical context for triptorelin use that informs coding decisions. When input fields were not provided, the publication notes those items as not available.
This summary serves clinicians, revenue cycle staff, and policy analysts seeking a national perspective on billing and policy implications for injectable triptorelin.
Billing Code Overview
HCPCS Level II code J3315 represents an injection of triptorelin pamoate, 3.75 mg. This code denotes a single administration of a gonadotropin-releasing hormone (GnRH) agonist formulation used in clinical settings for conditions managed by hormonal suppression.
Service type: Injection medication administration
Typical site of service: Outpatient clinic or physician office, ambulatory infusion center, or hospital outpatient department
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult assigned female at birth with symptomatic endometriosis or uterine fibroids presenting to a gynecology clinic for hormonal suppression prior to surgery or as medical management. The clinician documents diagnosis, reviews prior imaging and labs, obtains informed consent, and schedules a monthly intramuscular or deep subcutaneous injection of triptorelin pamoate 3.75 mg (J3315). Nursing verifies patient identity, reviews allergies and pregnancy status, prepares the single-dose vial or prefilled syringe, administers the medication (usually in the gluteal or deltoid region), observes the patient for immediate adverse reaction for 15–30 minutes, and documents lot number, route, site, and patient response in the medical record. Billing uses the HCPCS Level II code J3315 for the drug; encounter documentation should include indication, dose, administration route, date/time, and any relevant prior authorization or medical necessity rationale when required by payors.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier/Not specified | Use when no specific modifier applies and payer requires a default code. |